Will Trimble (TRMB) Beat Estimates Again in Its Next Earnings Report? — Positive
TRMB Zacks Investment Research — January 27, 2026Trimble (TRMB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Option Care (OPCH) Could Beat Earnings Estimates Again — Positive
OPCH Zacks Investment Research — January 27, 2026Option Care (OPCH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will US Foods (USFD) Beat Estimates Again in Its Next Earnings Report? — Positive
USFD Zacks Investment Research — January 27, 2026US Foods (USFD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Valley National (VLY) Could Beat Earnings Estimates Again — Positive
VLY Zacks Investment Research — January 27, 2026Valley National (VLY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Universal Health Services (UHS) Beat Estimates Again in Its Next Earnings Report? — Positive
UHS Zacks Investment Research — January 27, 2026Universal Health Services (UHS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
XLE vs VDE: Which Energy ETF Is a Better Buy Today? — Positive
VDE XLE 24/7 Wall Street — January 27, 2026Passive investors looking to take on a more contrarian position may wish to consider some of the sectors that most investors may be ignoring as the rise of the artificial intelligence (AI) boom continues.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of First Solar, Inc. - FSLR — Neutral
FSLR GlobeNewsWire — January 27, 2026INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of First Solar, Inc. -, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of First Solar, Inc. (“First Solar” or the “Company”) (NASDAQ: FSLR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
FRMI INVESTOR ALERT: Fermi Inc. (FRMI) Slapped With Securities Class Action Over IPO And Subsequent Disclosures -- Hagens Berman — Neutral
FRMI PRNewsWire — January 27, 2026FRMI Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, Jan. 27, 2026 /PRNewswire/ -- National shareholder rights firm Hagens Berman is notifying investors in Fermi Inc. (NASDAQ: FRMI) of the upcoming March 6, 2026, lead plaintiff deadline in a pending securities class action. Hagens Berman is investigating the alleged claims that Fermi IPO materials and subsequent disclosures misled investors regarding tenant demand and funding for its flagship "Project Matador" AI campus.
INTEGER HOLDINGS CORPORATION (NYSE: ITGR) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Integer Holdings Corporation Investors of Upcoming Deadline — Neutral
ITGR GlobeNewsWire — January 27, 2026Integer Holdings Shareholders Between July 25, 2024 and October 22, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
Ardent Health (ARDT) Facing Securities Class Action Amid Receivables and Reserves Issues Driving 33% Plunge - Hagens Berman — Neutral
ARDT PRNewsWire — January 27, 2026SAN FRANCISCO, Jan. 27, 2026 /PRNewswire/ -- National shareholder rights firm Hagens Berman is notifying Ardent Health, Inc. (NYSE: ARDT) investors that a securities class action lawsuit has been filed against the company and certain of its executives following the company's disastrous Q3 2025 financial results. Hagens Berman is investigating the alleged claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA — Neutral
VNDA GlobeNewsWire — January 27, 2026NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceuticals Inc. (“Vanda” or the “Company”) (NASDAQ: VNDA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
F5, INC. (NASDAQ: FFIV) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds F5, Inc. Investors of Upcoming Deadline — Neutral
FFIV GlobeNewsWire — January 27, 2026NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds F5, Inc. (“F5” or the “Company”) (NASDAQ: FFIV) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The F5 Class Action Lawsuit?
Here's how Amazon is looking to take on Walmart at its own game — Positive
AMZN WMT Market Watch — January 27, 2026Amazon is looking into opening a supercenter retail location, while closing its Amazon Go and Amazon Fresh physical stores.
Is Oracle's Rising Cloud CapEx Driving Its Next Growth Phase? — Positive
ORCL Zacks Investment Research — January 27, 2026ORCL is ramping cloud CapEx to $50B as AI and enterprise demand surge, betting GPU-rich data centers can unlock faster revenue growth.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Wealthfront Corporation - WLTH — Neutral
WLTH GlobeNewsWire — January 27, 2026NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Wealthfront Corporation (“Wealthfront” or the “Company”) (NASDAQ: WLTH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
BellRing Brands (BRBR) Facing Securities Class Action Amid Questions About Destocking, Consumption and Competition - Hagens Berman — Neutral
BRBR PRNewsWire — January 27, 2026SAN FRANCISCO, Jan. 27, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against BellRing Brands, Inc. (NYSE: BRBR) and certain of its executives. The lawsuit follows BellRing's disastrous May 6, 2025, Q2 2025 and August 4, 2025, Q3 2025 earnings reports, each of which drove the price of BellRing shares sharply lower.
ComEd Keeps Power Affordable and Reliable for Customers, While Delivering Clean Energy Advancements in 2025 — Neutral
EXC Business Wire — January 27, 2026CHICAGO--(BUSINESS WIRE)--ComEd achieved pivotal advancements in 2025 to meet the energy needs of over 9 million people across northern Illinois. While delivering nation-leading electric utility reliability, ComEd connected tens of thousands of customers to renewable energy resources, awarding more than $500 million in rebates and energy efficiency (EE) savings programs to reduce upfront barriers to EVs, solar and battery storage, heat pumps, and energy efficiency savings technologies to help l.
Silver is retail traders' new obsession as record numbers bet on rally — and on a crash — Positive
SIL SILJ SIVR SLV SLVP CNBC — January 27, 2026Retail investors have rushed into the iShares Silver Trust (SLV) exchange-traded fund as the metal has surged. One analyst described silver as the new epicenter of retail fervor.
Intellia Moves Forward As FDA Removes Trial Hold For Rare Disorder — Positive
NTLA Benzinga — January 27, 2026The U.S. Food and Drug Administration (FDA) on Tuesday said it removed the clinical hold on Intellia Therapeutics Inc.‘s (NASDAQ: NTLA) Investigational New Drug application (IND) for the MAGNITUDE-2 Phase 3 trial of nexiguran ziclumeran (nex-z) for hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN).
MDV is an internally managed REIT focused on single-tenant net-lease industrial manufacturing properties, recently increasing its dividend by 2.6%. MDV faces challenges due to specialized assets, high capital costs, and sector-trailing AFFO multiples, limiting its ability to reinvest or grow efficiently. The CEO acknowledges MDV's persistent undervaluation—estimated at 20%-40% below intrinsic value—and is open to strategic alternatives, including a potential sale.